Journal of Diabetes Research

Journal of Diabetes Research / 2020 / Article

Corrigendum | Open Access

Volume 2020 |Article ID 5498528 | https://doi.org/10.1155/2020/5498528

Yuqi Liu, Juan Li, Jinfang Ma, Nanwei Tong, "Corrigendum to “The Threshold of the Severity of Diabetic Retinopathy below Which Intensive Glycemic Control Is Beneficial in Diabetic Patients: Estimation Using Data from Large Randomized Clinical Trials” by Yuqi Liu,Juan Li, Jinfang Ma, Nanwei Tong", Journal of Diabetes Research, vol. 2020, Article ID 5498528, 1 page, 2020. https://doi.org/10.1155/2020/5498528

Corrigendum to “The Threshold of the Severity of Diabetic Retinopathy below Which Intensive Glycemic Control Is Beneficial in Diabetic Patients: Estimation Using Data from Large Randomized Clinical Trials” by Yuqi Liu,Juan Li, Jinfang Ma, Nanwei Tong

Received13 May 2020
Accepted14 May 2020
Published30 Jun 2020

In the article titled “The Threshold of the Severity of Diabetic Retinopathy below Which Intensive Glycemic Control Is Beneficial in Diabetic Patients: Estimation Using Data from Large Randomized Clinical Trials” [1], there was an error in the Acknowledgments section, where Grant No. 0040205301D50 should be corrected to Grant No. 2015SZ0228.

References

  1. Y. Liu, J. Li, J. Ma, and N. Tong, “The threshold of the severity of diabetic retinopathy below which intensive glycemic control is beneficial in diabetic patients: estimation using data from large randomized clinical trials,” Journal of Diabetes Research, vol. 2020, Article ID 8765139, 6 pages, 2020. View at: Publisher Site | Google Scholar

Copyright © 2020 Yuqi Liu et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.


More related articles

 PDF Download Citation Citation
 Download other formatsMore
 Order printed copiesOrder
Views58
Downloads104
Citations

Related articles

We are committed to sharing findings related to COVID-19 as quickly as possible. We will be providing unlimited waivers of publication charges for accepted research articles as well as case reports and case series related to COVID-19. Review articles are excluded from this waiver policy. Sign up here as a reviewer to help fast-track new submissions.